Outlook Therapeutics Inc (OQ:OTLK)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for OTLK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 4th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 6/23 Oct 4/23 Gangolli Julian S Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 370,282  
Oct 5/23 Oct 4/23 Haller Julia A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 210,225  
Oct 5/23 Oct 4/23 Huang Andong Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 191,113  
Oct 5/23 Oct 4/23 Auffarth Gerd Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 210,225  
Oct 5/23 Oct 4/23 Haddadin Yezan Munther Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 358,337  
Oct 5/23 Oct 4/23 Sukhtian Faisal Ghiath Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 372,671  
Oct 5/23 Oct 4/23 Hilzinger Kurt J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 286,670  
Apr 21/23 Apr 20/23 Dagnon Terry Direct Ownership Common Stock S - Open market or private sale -520,000 $1.14
Apr 19/23 Apr 17/23 Dagnon Terry Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 192,143  
Apr 19/23 Apr 17/23 Evanson Jeff Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 192,143  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for OTLK within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 4th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Oct 6/23 Oct 4/23 Gangolli Julian S Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 370,282  
Oct 5/23 Oct 4/23 Haller Julia A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 210,225  
Oct 5/23 Oct 4/23 Huang Andong Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 191,113  
Oct 5/23 Oct 4/23 Auffarth Gerd Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 210,225  
Oct 5/23 Oct 4/23 Haddadin Yezan Munther Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 358,337  
Oct 5/23 Oct 4/23 Sukhtian Faisal Ghiath Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 372,671  
Oct 5/23 Oct 4/23 Hilzinger Kurt J Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 286,670  
Apr 21/23 Apr 20/23 Dagnon Terry Direct Ownership Common Stock S - Open market or private sale -520,000 $1.14
Apr 19/23 Apr 17/23 Dagnon Terry Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 192,143  
Apr 19/23 Apr 17/23 Evanson Jeff Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 192,143  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $OTLK

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Medpace Holdings (OQ:MEDP)
Disc Medicine (OQ:IRON)
Dyne Therapeutics (OQ:DYN)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.